Is PepGen Inc. (PEPG) a Buy, Sell, or Hold?
NASDAQ : PEPG
PepGen Inc. — Insider Trades
$2.85 USD
$0.44 (18.26%)
- Volume
- 3.21M
- Average Volume
- 842.17K
- Market Capitalization
- $197.13M
- P/E Ratio
- -1.90
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $7.80
- Year Low
- $1.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.36
Insider Activity Summary (Last 12 Months)
Insiders Buying
35
Insiders Selling
17
Amount of Insider Selling
$2.04M
PEPG Insider Buying/Selling by Quarter
PEPG Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Wyman Lisa | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Resnick Joshua | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Mayer Howard | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Finer Mitchell H. | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Dable Habib J | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| HENSON HEIDI | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| KEATING LAURIE | director | 2026-06-18 | A-Award | 1.79 | 2026-06-22 |
| Kasraian Kasra | officer: Chief Technical Officer | 2026-05-21 | S-Sale | 1.4107 | 2026-05-26 |
| STRECK PAUL | officer: EVP, Head of R&D | 2026-03-04 | S-Sale | 6.23 | 2026-03-06 |
| STRECK PAUL | officer: EVP, Head of R&D | 2026-03-04 | S-Sale | 6.288 | 2026-03-06 |
| Donnelly Noel | officer: Chief Financial Officer | 2026-03-04 | S-Sale | 6.23 | 2026-03-06 |
| Donnelly Noel | officer: Chief Financial Officer | 2026-03-04 | S-Sale | 6.325 | 2026-03-06 |
| McArthur James G | director, officer: President and CEO | 2026-03-04 | S-Sale | 6.23 | 2026-03-06 |
| McArthur James G | director, officer: President and CEO | 2026-03-04 | S-Sale | 6.325 | 2026-03-06 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2026-03-01 | A-Award | 6.22 | 2026-03-02 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2026-03-01 | A-Award | 0 | 2026-03-02 |
| Kasraian Kasra | officer: Chief Technical Officer | 2026-03-01 | A-Award | 6.22 | 2026-03-02 |
| Kasraian Kasra | officer: Chief Technical Officer | 2026-03-01 | A-Award | 0 | 2026-03-02 |
| STRECK PAUL | officer: EVP, Head of R&D | 2026-03-01 | A-Award | 6.22 | 2026-03-02 |
| STRECK PAUL | officer: EVP, Head of R&D | 2026-03-01 | A-Award | 0 | 2026-03-02 |
| Donnelly Noel | officer: Chief Financial Officer | 2026-03-01 | A-Award | 6.22 | 2026-03-02 |
| Donnelly Noel | officer: Chief Financial Officer | 2026-03-01 | A-Award | 0 | 2026-03-02 |
| McArthur James G | director, officer: President and CEO | 2026-03-01 | A-Award | 6.22 | 2026-03-02 |
| McArthur James G | director, officer: President and CEO | 2026-03-01 | A-Award | 0 | 2026-03-02 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-11-04 | D-Return | 9.83 | 2025-12-18 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-11-04 | D-Return | 9.83 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | D-Return | 12 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | D-Return | 15.25 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | D-Return | 16.62 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | D-Return | 8.96 | 2025-12-18 |
| McArthur James G | director, officer: President and CEO | 2025-11-04 | D-Return | 11.23 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | A-Award | 4.53 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | D-Return | 12 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | D-Return | 10.88 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | D-Return | 15.25 | 2025-12-18 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-11-04 | D-Return | 16.62 | 2025-12-18 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-12-08 | A-Award | 5.59 | 2025-12-10 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-12-08 | A-Award | 0 | 2025-12-10 |
| Vittiglio Joseph | officer | 2025-12-08 | 0 | 2025-12-10 | |
| Oxford Science Enterprises plc | other: Former 10% Owner | 2025-09-30 | P-Purchase | 3.2 | 2025-10-01 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-09-26 | P-Purchase | 3.2 | 2025-09-30 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| Mayer Howard | director | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| HENSON HEIDI | director | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| KEATING LAURIE | director | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| Dable Habib J | director | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| Resnick Joshua | director | 2025-06-04 | A-Award | 1.51 | 2025-06-06 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-05-30 | P-Purchase | 1.241 | 2025-06-02 |
| Kasraian Kasra | officer: Chief Technical Officer | 2025-05-20 | A-Award | 1.58 | 2025-05-21 |
| Kasraian Kasra | officer: Chief Technical Officer | 2025-05-20 | A-Award | 0 | 2025-05-21 |
| Kasraian Kasra | officer | 2025-05-20 | 0 | 2025-05-21 | |
| McArthur James G | director, officer: President and CEO | 2025-04-17 | P-Purchase | 1.355 | 2025-04-22 |
| McArthur James G | director, officer: President and CEO | 2025-04-08 | P-Purchase | 1.15 | 2025-04-09 |
| Finer Mitchell H. | director | 2025-03-27 | A-Award | 1.61 | 2025-03-31 |
| Wyman Lisa | director | 2025-03-27 | A-Award | 1.61 | 2025-03-31 |
| Finer Mitchell H. | director: | 2025-03-27 | 0 | 2025-03-31 | |
| Wyman Lisa | director: | 2025-03-27 | 0 | 2025-03-31 | |
| DeLena Mary Beth | officer: General Counsel | 2025-03-03 | A-Award | 2.81 | 2025-03-05 |
| DeLena Mary Beth | officer: General Counsel | 2025-03-03 | A-Award | 0 | 2025-03-05 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-03-03 | A-Award | 2.81 | 2025-03-05 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-03-03 | A-Award | 0 | 2025-03-05 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-03-03 | A-Award | 2.81 | 2025-03-05 |
| STRECK PAUL | officer: EVP, Head of R&D | 2025-03-03 | A-Award | 0 | 2025-03-05 |
| McArthur James G | director, officer: President and CEO | 2025-03-03 | A-Award | 2.81 | 2025-03-05 |
| McArthur James G | director, officer: President and CEO | 2025-03-03 | A-Award | 0 | 2025-03-05 |
| DeLena Mary Beth | officer: General Counsel | 2025-02-24 | A-Award | 0 | 2025-02-26 |
| DeLena Mary Beth | officer: General Counsel | 2025-02-26 | S-Sale | 1.68 | 2025-02-26 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-02-24 | A-Award | 0 | 2025-02-26 |
| Donnelly Noel | officer: Chief Financial Officer | 2025-02-26 | S-Sale | 1.68 | 2025-02-26 |
| STRECK PAUL | officer: EVP, Head of R&D | 2024-08-19 | A-Award | 9.83 | 2024-08-20 |
| STRECK PAUL | officer: EVP, Head of R&D | 2024-08-19 | A-Award | 9.83 | 2024-08-20 |
| STRECK PAUL | officer | 2024-08-19 | 0 | 2024-08-20 | |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-24 | M-Exempt | 10.21 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-25 | M-Exempt | 10.21 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-25 | M-Exempt | 10.21 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-24 | M-Exempt | 10.21 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-24 | S-Sale | 18.0051 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-25 | S-Sale | 18.0612 | 2024-07-26 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-18 | M-Exempt | 10.21 | 2024-07-19 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-18 | M-Exempt | 10.21 | 2024-07-19 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-18 | S-Sale | 18.2023 | 2024-07-19 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-12 | M-Exempt | 10.21 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-16 | M-Exempt | 10.21 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-16 | M-Exempt | 10.21 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-12 | M-Exempt | 10.21 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-12 | S-Sale | 18.0448 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-16 | S-Sale | 18.0049 | 2024-07-16 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-01 | M-Exempt | 10.21 | 2024-07-03 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-02 | M-Exempt | 10.21 | 2024-07-03 |
| Mellion Michelle L | officer: Chief Medical Officer | 2024-07-01 | M-Exempt | 10.21 | 2024-07-03 |